Page last updated: 2024-09-04

phosphorus and Dyslipidemia

phosphorus has been researched along with Dyslipidemia in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's5 (71.43)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Singh, A; Tandon, C; Tandon, S1
Bostom, A; Ix, JH; Rao, M; Steffes, M1
Escobar-Jiménez, F; García-Castro, JM; García-Martín, A; Muñoz-Torres, M; Quesada-Charneco, M; Reyes-García, R1
Bostom, AG; Hanlon, WA; Kuznetsova, O; Maccubbin, D; Tipping, D1
Bostom, AG; Harris, WS; Hu, S; Shearer, GC; Steffes, MW1
Aniort, J; Deteix, P; Garrouste, C; Hadj Abdelkader, M; Heng, AE; Kaysi, S; Philipponnet, C1
Ammirati, AL; Cendoroglo, M; Dalboni, MA; Draibe, SA; Fernandes Canziani, ME1

Reviews

1 review(s) available for phosphorus and Dyslipidemia

ArticleYear
An update on vascular calcification and potential therapeutics.
    Molecular biology reports, 2021, Volume: 48, Issue:1

    Topics: Atherosclerosis; Calcimimetic Agents; Calcium; Denosumab; Diabetes Mellitus; Diphosphonates; Dyslipidemias; Enzyme Inhibitors; Homeostasis; Hypertension; Inositol Phosphates; Phosphorus; Renal Insufficiency, Chronic; Thiosulfates; Vascular Calcification; Vitamin D; Vitamin K

2021

Trials

3 trial(s) available for phosphorus and Dyslipidemia

ArticleYear
Effect of niacin on FGF23 concentration in chronic kidney disease.
    American journal of nephrology, 2014, Volume: 39, Issue:6

    Topics: Aged; Calcium; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hypolipidemic Agents; Indoles; Male; Middle Aged; Niacin; Parathyroid Hormone; Phosphorus; Receptors, Immunologic; Receptors, Prostaglandin; Renal Insufficiency, Chronic

2014
Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial.
    Clinical journal of the American Society of Nephrology : CJASN, 2010, Volume: 5, Issue:4

    Topics: Aged; Biomarkers; Calcium; Chronic Disease; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Glomerular Filtration Rate; Humans; Hyperphosphatemia; Hypolipidemic Agents; Hypophosphatemia; Indoles; Kidney Diseases; Male; Middle Aged; Niacin; Phosphorus; Receptors, Immunologic; Receptors, Prostaglandin; Severity of Illness Index; Time Factors

2010
Once-daily extended-release niacin lowers serum phosphorus concentrations in patients with metabolic syndrome dyslipidemia.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2011, Volume: 57, Issue:1

    Topics: Calcium; Delayed-Action Preparations; Drug Administration Schedule; Dyslipidemias; Glomerular Filtration Rate; Humans; Hypolipidemic Agents; Metabolic Syndrome; Niacin; Phosphorus; Serum Albumin

2011

Other Studies

3 other study(ies) available for phosphorus and Dyslipidemia

ArticleYear
Cardiovascular risk factors in patients with asymptomatic primary hyperparathyroidism.
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2014, Volume: 61, Issue:10

    Topics: Adult; Aged; Asymptomatic Diseases; Body Mass Index; Calcium; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus; Dyslipidemias; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Primary; Hypertension; Male; Middle Aged; Obesity; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Retrospective Studies; Risk Factors

2014
Chronic renal failure complications and management in kidney transplanted and nontransplanted patients.
    Transplantation proceedings, 2012, Volume: 44, Issue:10

    Topics: Anemia; Biomarkers; Blood Pressure; Chi-Square Distribution; Dyslipidemias; Ferritins; Guideline Adherence; Humans; Hypertension; Kidney Failure, Chronic; Kidney Transplantation; Lipids; Outcome and Process Assessment, Health Care; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Renal Dialysis; Retrospective Studies; Treatment Outcome

2012
Coronary artery calcification, systemic inflammation markers and mineral metabolism in a peritoneal dialysis population.
    Nephron. Clinical practice, 2006, Volume: 104, Issue:1

    Topics: Adult; Age Factors; Aged; Antihypertensive Agents; C-Reactive Protein; Calcinosis; Calcium; Cholesterol, LDL; Coronary Artery Disease; Dyslipidemias; Female; Humans; Hypertension; Inflammation; Kidney Failure, Chronic; Logistic Models; Male; Middle Aged; Peritoneal Dialysis; Phosphorus; Tomography, X-Ray Computed

2006